Literature DB >> 21491381

Carotid endarterectomy for symptomatic carotid stenosis.

Kittipan Rerkasem1, Peter M Rothwell.   

Abstract

BACKGROUND: Severe narrowing (stenosis) of the carotid artery is an important cause of stroke. Surgical treatment (carotid endarterectomy) may reduce the risk of stroke, but carries a risk of operative complications.
OBJECTIVES: To determine the balance of benefit versus risk of endarterectomy plus best medical management compared with best medical management alone in patients with a recent symptomatic carotid stenosis (i.e. transient ischaemic attack (TIA) or non-disabling stroke). SEARCH STRATEGY: We searched the Cochrane Stroke Group Trials Register (July 2010), MEDLINE (1966 to March 2010), EMBASE (1990 to March 2010) and three other databases, and handsearched relevant journals and reference lists. SELECTION CRITERIA: Randomised controlled trials. DATA COLLECTION AND ANALYSIS: Two review authors independently selected studies and extracted the data. MAIN
RESULTS: We included three trials. As the trials differed in the methods of measurement of carotid stenosis and in the definition of stroke, we did a pooled analysis of individual patient data on 6092 patients (35,000 patient years of follow-up) after reassessment of the carotid angiograms and outcomes from all three trials using the primary electronic data files and redefined outcome events where necessary to achieve comparability.On re-analysis, there were no statistically significant differences between the trials in the risks of any of the main outcomes in either of the treatment groups or in the effects of surgery. Surgery increased the five-year risk of ipsilateral ischaemic stroke in patients with less than 30% stenosis (N = 1746, absolute risk reduction (ARR) -2.2%, P = 0.05), had no significant effect in patients with 30% to 49% stenosis (N = 1429, ARR 3.2%, P = 0.6), was of marginal benefit in patients with 50% to 69% stenosis (N = 1549, ARR 4.6%, P = 0.04), and was highly beneficial in patients with 70% to 99% stenosis without near-occlusion (N = 1095, ARR 16.0%, P < 0.001). However, there was no evidence of benefit (N = 262, ARR -1.7%, P = 0.9) in patients with near-occlusions.Benefit from surgery was greatest in men, patients aged 75 years or over, and patients randomised within two weeks after their last ischaemic event and fell rapidly with increasing delay. AUTHORS'
CONCLUSIONS: Endarterectomy is of some benefit for 50% to 69% symptomatic stenosis and highly beneficial for 70% to 99% stenosis without near-occlusion. Benefit in patients with carotid near-occlusion is marginal in the short-term and uncertain in the long-term. These results are generalisable only to surgically-fit patients operated on by surgeons with low complication rates (less than 7% risk of stroke and death). Benefit from endarterectomy depends not only on the degree of carotid stenosis, but also on several other factors, including the delay to surgery after the presenting event.

Entities:  

Mesh:

Year:  2011        PMID: 21491381     DOI: 10.1002/14651858.CD001081.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  28 in total

1.  Dual antiplatelet therapy for acute minor ischemic stroke or transient ischemic attack.

Authors:  Stavros K Kakkos; John Ellul; Ioannis Ntouvas; Spyros I Papadoulas
Journal:  Ann Transl Med       Date:  2015-08

Review 2.  Management of carotid stenosis in women: consensus document.

Authors:  Paola De Rango; Martin M Brown; Didier Leys; Leys Didier; Virginia J Howard; Wesley S Moore; Maurizio Paciaroni; Peter Ringleb; Caron Rockman; Valeria Caso
Journal:  Neurology       Date:  2013-06-11       Impact factor: 9.910

3.  (18)F-FDG imaging of human atherosclerotic carotid plaques reflects gene expression of the key hypoxia marker HIF-1α.

Authors:  Sune Folke Pedersen; Martin Græbe; Anne Mette F Hag; Liselotte Højgaard; Henrik Sillesen; Andreas Kjær
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-09-19

4.  Variable life adjusted display methodology for continuous performance monitoring of carotid endarterectomy.

Authors:  G Kuhan; D P McCollum; P M Renwick; I C Chetter; P T McCollum
Journal:  Ann R Coll Surg Engl       Date:  2017-10-19       Impact factor: 1.891

5.  Regional variation in patient outcomes in carotid artery disease treatment in the Vascular Quality Initiative.

Authors:  Katie E Shean; Thomas F X O'Donnell; Sarah E Deery; Alexander B Pothof; Joseph R Schneider; Caron B Rockman; Brian W Nolan; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2018-03-20       Impact factor: 4.268

Review 6.  Evaluation and Management of Atherosclerotic Carotid Stenosis.

Authors:  James F Meschia; James P Klaas; Robert D Brown; Thomas G Brott
Journal:  Mayo Clin Proc       Date:  2017-07       Impact factor: 7.616

7.  The effects of centralisation of vascular surgical services in the Bath, Bristol and Weston area on the carotid endarterectomy pathway.

Authors:  E Partridge; M Brooks; C Curd; V Davis; C Oates; D McGeeney
Journal:  Ann R Coll Surg Engl       Date:  2017-07-06       Impact factor: 1.891

Review 8.  Advances in stroke prevention.

Authors:  Ayesha Z Sherzai; Mitchell S V Elkind
Journal:  Ann N Y Acad Sci       Date:  2015-03       Impact factor: 5.691

9.  Optimal MRI sequence for identifying occlusion location in acute stroke: which value of time-resolved contrast-enhanced MRA?

Authors:  A Le Bras; H Raoult; J-C Ferré; T Ronzière; J-Y Gauvrit
Journal:  AJNR Am J Neuroradiol       Date:  2015-03-12       Impact factor: 3.825

Review 10.  Age and gender disparities in the risk of carotid revascularization procedures.

Authors:  Sotirios Giannopoulos; Aristeidis H Katsanos; Spyros N Vasdekis; Efstathios Boviatsis; Konstantinos Iota Voumvourakis; Georgios Tsivgoulis
Journal:  Neurol Sci       Date:  2013-05-12       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.